KU Leuven-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2021

  1. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433

2012

  1. Immediate and late benefits of treating very elderly people with hypertension: Results from active treatment extension to hypertension in the very elderly randomised controlled trial

    BMJ (Online), Vol. 344, Núm. 7839

2003

  1. Results of the pilot study for the Hypertension in the Very Elderly Trial

    Journal of Hypertension, Vol. 21, Núm. 12, pp. 2409-2417

2002

  1. The prevention of dementia with antihypertensive treatment: New evidence from the systolic hypertension in Europe (syst-eur) study

    Archives of Internal Medicine, Vol. 162, Núm. 18, pp. 2046-2052

2001

  1. Hypertension in the very elderly trial (HYVET): Protocol for the main trial

    Drugs and Aging, Vol. 18, Núm. 3, pp. 151-164

1998

  1. Calcium channel blockade and cardiovascular prognosis in the european trial on isolated systolic hypertension

    Hypertension, Vol. 32, Núm. 3, pp. 410-416

  2. Conventional and ambulatory measurements of blood pressure in old patients with isolated systolic hypertension: Baseline observations in the Syst-Eur trial

    Blood Pressure Monitoring

  3. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

    Lancet, Vol. 352, Núm. 9137, pp. 1347-1351

1996

  1. Conventional and ambulatory blood pressure measurement in older patients with isolated systolic hypertension: Second progress report on the ambulatory blood pressure monitoring project in the Syst-Eur trial

    Blood Pressure Monitoring, Vol. 1, Núm. 2, pp. 95-103